Global Biosimilars/Follow-on-Biologics Market Insight and Forecast to 2026
The research team projects that the Biosimilars/Follow-on-Biologics market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Novartis
Merck Group
LG Life Sciences
Synthon Pharmaceuticals
Hospira
Teva Pharmaceutical Industries
Genentech (Roche Group)
Biocon
Celltrion
Biogen idec, Inc.
By Type
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
By Application
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biosimilars/Follow-on-Biologics 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biosimilars/Follow-on-Biologics Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biosimilars/Follow-on-Biologics Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biosimilars/Follow-on-Biologics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Novartis
Merck Group
LG Life Sciences
Synthon Pharmaceuticals
Hospira
Teva Pharmaceutical Industries
Genentech (Roche Group)
Biocon
Celltrion
Biogen idec, Inc.
By Type
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
By Application
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biosimilars/Follow-on-Biologics 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biosimilars/Follow-on-Biologics Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biosimilars/Follow-on-Biologics Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biosimilars/Follow-on-Biologics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilars/Follow-on-Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human growth hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.4.8 Peptide
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biosimilars/Follow-on-Biologics Market Share by Application: 2021-2026
1.5.2 Blood disorders
1.5.3 Oncology diseases
1.5.4 Chronic and autoimmune diseases
1.5.5 Growth hormone deficiencies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biosimilars/Follow-on-Biologics Market Perspective (2021-2026)
2.2 Biosimilars/Follow-on-Biologics Growth Trends by Regions
2.2.1 Biosimilars/Follow-on-Biologics Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biosimilars/Follow-on-Biologics Historic Market Size by Regions (2015-2020)
2.2.3 Biosimilars/Follow-on-Biologics Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biosimilars/Follow-on-Biologics Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biosimilars/Follow-on-Biologics Average Price by Manufacturers (2015-2020)
4 BIOSIMILARS/FOLLOW-ON-BIOLOGICS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.1.2 Biosimilars/Follow-on-Biologics Key Players in North America (2015-2020)
4.1.3 North America Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.1.4 North America Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.2.2 Biosimilars/Follow-on-Biologics Key Players in East Asia (2015-2020)
4.2.3 East Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.2.4 East Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.3.2 Biosimilars/Follow-on-Biologics Key Players in Europe (2015-2020)
4.3.3 Europe Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.3.4 Europe Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.4.2 Biosimilars/Follow-on-Biologics Key Players in South Asia (2015-2020)
4.4.3 South Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.4.4 South Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.5.2 Biosimilars/Follow-on-Biologics Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.6.2 Biosimilars/Follow-on-Biologics Key Players in Middle East (2015-2020)
4.6.3 Middle East Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.6.4 Middle East Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.7.2 Biosimilars/Follow-on-Biologics Key Players in Africa (2015-2020)
4.7.3 Africa Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.7.4 Africa Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.8.2 Biosimilars/Follow-on-Biologics Key Players in Oceania (2015-2020)
4.8.3 Oceania Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.8.4 Oceania Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.9.2 Biosimilars/Follow-on-Biologics Key Players in South America (2015-2020)
4.9.3 South America Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.9.4 South America Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.10.2 Biosimilars/Follow-on-Biologics Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.10.4 Rest of the World Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5 BIOSIMILARS/FOLLOW-ON-BIOLOGICS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biosimilars/Follow-on-Biologics Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biosimilars/Follow-on-Biologics Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biosimilars/Follow-on-Biologics Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biosimilars/Follow-on-Biologics Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biosimilars/Follow-on-Biologics Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biosimilars/Follow-on-Biologics Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biosimilars/Follow-on-Biologics Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biosimilars/Follow-on-Biologics Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biosimilars/Follow-on-Biologics Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biosimilars/Follow-on-Biologics Consumption by Countries
5.10.2 Kazakhstan
6 BIOSIMILARS/FOLLOW-ON-BIOLOGICS SALES MARKET BY TYPE (2015-2026)
6.1 Global Biosimilars/Follow-on-Biologics Historic Market Size by Type (2015-2020)
6.2 Global Biosimilars/Follow-on-Biologics Forecasted Market Size by Type (2021-2026)
7 BIOSIMILARS/FOLLOW-ON-BIOLOGICS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biosimilars/Follow-on-Biologics Historic Market Size by Application (2015-2020)
7.2 Global Biosimilars/Follow-on-Biologics Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOSIMILARS/FOLLOW-ON-BIOLOGICS BUSINESS
8.1 Novartis
8.1.1 Novartis Company Profile
8.1.2 Novartis Biosimilars/Follow-on-Biologics Product Specification
8.1.3 Novartis Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Merck Group
8.2.1 Merck Group Company Profile
8.2.2 Merck Group Biosimilars/Follow-on-Biologics Product Specification
8.2.3 Merck Group Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 LG Life Sciences
8.3.1 LG Life Sciences Company Profile
8.3.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Specification
8.3.3 LG Life Sciences Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Synthon Pharmaceuticals
8.4.1 Synthon Pharmaceuticals Company Profile
8.4.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Specification
8.4.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Hospira
8.5.1 Hospira Company Profile
8.5.2 Hospira Biosimilars/Follow-on-Biologics Product Specification
8.5.3 Hospira Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Teva Pharmaceutical Industries
8.6.1 Teva Pharmaceutical Industries Company Profile
8.6.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Specification
8.6.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Genentech (Roche Group)
8.7.1 Genentech (Roche Group) Company Profile
8.7.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Specification
8.7.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Biocon
8.8.1 Biocon Company Profile
8.8.2 Biocon Biosimilars/Follow-on-Biologics Product Specification
8.8.3 Biocon Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Celltrion
8.9.1 Celltrion Company Profile
8.9.2 Celltrion Biosimilars/Follow-on-Biologics Product Specification
8.9.3 Celltrion Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Biogen idec, Inc.
8.10.1 Biogen idec, Inc. Company Profile
8.10.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Specification
8.10.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biosimilars/Follow-on-Biologics (2021-2026)
9.2 Global Forecasted Revenue of Biosimilars/Follow-on-Biologics (2021-2026)
9.3 Global Forecasted Price of Biosimilars/Follow-on-Biologics (2015-2026)
9.4 Global Forecasted Production of Biosimilars/Follow-on-Biologics by Region (2021-2026)
9.4.1 North America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.9 South America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biosimilars/Follow-on-Biologics by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.2 East Asia Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.3 Europe Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Countriy
10.4 South Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.5 Southeast Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.6 Middle East Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.7 Africa Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.8 Oceania Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.9 South America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.10 Rest of the world Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biosimilars/Follow-on-Biologics Distributors List
11.3 Biosimilars/Follow-on-Biologics Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biosimilars/Follow-on-Biologics Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilars/Follow-on-Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Biosimilars/Follow-on-Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human growth hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.4.8 Peptide
1.4.9 Others
1.5 Market by Application
1.5.1 Global Biosimilars/Follow-on-Biologics Market Share by Application: 2021-2026
1.5.2 Blood disorders
1.5.3 Oncology diseases
1.5.4 Chronic and autoimmune diseases
1.5.5 Growth hormone deficiencies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biosimilars/Follow-on-Biologics Market Perspective (2021-2026)
2.2 Biosimilars/Follow-on-Biologics Growth Trends by Regions
2.2.1 Biosimilars/Follow-on-Biologics Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biosimilars/Follow-on-Biologics Historic Market Size by Regions (2015-2020)
2.2.3 Biosimilars/Follow-on-Biologics Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biosimilars/Follow-on-Biologics Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biosimilars/Follow-on-Biologics Average Price by Manufacturers (2015-2020)
4 BIOSIMILARS/FOLLOW-ON-BIOLOGICS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.1.2 Biosimilars/Follow-on-Biologics Key Players in North America (2015-2020)
4.1.3 North America Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.1.4 North America Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.2.2 Biosimilars/Follow-on-Biologics Key Players in East Asia (2015-2020)
4.2.3 East Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.2.4 East Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.3.2 Biosimilars/Follow-on-Biologics Key Players in Europe (2015-2020)
4.3.3 Europe Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.3.4 Europe Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.4.2 Biosimilars/Follow-on-Biologics Key Players in South Asia (2015-2020)
4.4.3 South Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.4.4 South Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.5.2 Biosimilars/Follow-on-Biologics Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.6.2 Biosimilars/Follow-on-Biologics Key Players in Middle East (2015-2020)
4.6.3 Middle East Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.6.4 Middle East Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.7.2 Biosimilars/Follow-on-Biologics Key Players in Africa (2015-2020)
4.7.3 Africa Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.7.4 Africa Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.8.2 Biosimilars/Follow-on-Biologics Key Players in Oceania (2015-2020)
4.8.3 Oceania Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.8.4 Oceania Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.9.2 Biosimilars/Follow-on-Biologics Key Players in South America (2015-2020)
4.9.3 South America Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.9.4 South America Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biosimilars/Follow-on-Biologics Market Size (2015-2026)
4.10.2 Biosimilars/Follow-on-Biologics Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biosimilars/Follow-on-Biologics Market Size by Type (2015-2020)
4.10.4 Rest of the World Biosimilars/Follow-on-Biologics Market Size by Application (2015-2020)
5 BIOSIMILARS/FOLLOW-ON-BIOLOGICS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biosimilars/Follow-on-Biologics Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biosimilars/Follow-on-Biologics Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biosimilars/Follow-on-Biologics Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biosimilars/Follow-on-Biologics Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biosimilars/Follow-on-Biologics Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biosimilars/Follow-on-Biologics Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biosimilars/Follow-on-Biologics Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biosimilars/Follow-on-Biologics Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biosimilars/Follow-on-Biologics Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biosimilars/Follow-on-Biologics Consumption by Countries
5.10.2 Kazakhstan
6 BIOSIMILARS/FOLLOW-ON-BIOLOGICS SALES MARKET BY TYPE (2015-2026)
6.1 Global Biosimilars/Follow-on-Biologics Historic Market Size by Type (2015-2020)
6.2 Global Biosimilars/Follow-on-Biologics Forecasted Market Size by Type (2021-2026)
7 BIOSIMILARS/FOLLOW-ON-BIOLOGICS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biosimilars/Follow-on-Biologics Historic Market Size by Application (2015-2020)
7.2 Global Biosimilars/Follow-on-Biologics Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOSIMILARS/FOLLOW-ON-BIOLOGICS BUSINESS
8.1 Novartis
8.1.1 Novartis Company Profile
8.1.2 Novartis Biosimilars/Follow-on-Biologics Product Specification
8.1.3 Novartis Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Merck Group
8.2.1 Merck Group Company Profile
8.2.2 Merck Group Biosimilars/Follow-on-Biologics Product Specification
8.2.3 Merck Group Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 LG Life Sciences
8.3.1 LG Life Sciences Company Profile
8.3.2 LG Life Sciences Biosimilars/Follow-on-Biologics Product Specification
8.3.3 LG Life Sciences Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Synthon Pharmaceuticals
8.4.1 Synthon Pharmaceuticals Company Profile
8.4.2 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Specification
8.4.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Hospira
8.5.1 Hospira Company Profile
8.5.2 Hospira Biosimilars/Follow-on-Biologics Product Specification
8.5.3 Hospira Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 Teva Pharmaceutical Industries
8.6.1 Teva Pharmaceutical Industries Company Profile
8.6.2 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Specification
8.6.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Genentech (Roche Group)
8.7.1 Genentech (Roche Group) Company Profile
8.7.2 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Specification
8.7.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Biocon
8.8.1 Biocon Company Profile
8.8.2 Biocon Biosimilars/Follow-on-Biologics Product Specification
8.8.3 Biocon Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Celltrion
8.9.1 Celltrion Company Profile
8.9.2 Celltrion Biosimilars/Follow-on-Biologics Product Specification
8.9.3 Celltrion Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Biogen idec, Inc.
8.10.1 Biogen idec, Inc. Company Profile
8.10.2 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Specification
8.10.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biosimilars/Follow-on-Biologics (2021-2026)
9.2 Global Forecasted Revenue of Biosimilars/Follow-on-Biologics (2021-2026)
9.3 Global Forecasted Price of Biosimilars/Follow-on-Biologics (2015-2026)
9.4 Global Forecasted Production of Biosimilars/Follow-on-Biologics by Region (2021-2026)
9.4.1 North America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.9 South America Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biosimilars/Follow-on-Biologics Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biosimilars/Follow-on-Biologics by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.2 East Asia Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.3 Europe Market Forecasted Consumption of Biosimilars/Follow-on-Biologics by Countriy
10.4 South Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.5 Southeast Asia Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.6 Middle East Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.7 Africa Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.8 Oceania Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.9 South America Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
10.10 Rest of the world Forecasted Consumption of Biosimilars/Follow-on-Biologics by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biosimilars/Follow-on-Biologics Distributors List
11.3 Biosimilars/Follow-on-Biologics Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biosimilars/Follow-on-Biologics Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Biosimilars/Follow-on-Biologics Market Share by Type: 2020 VS 2026
Table 2. Human growth hormone Features
Table 3. Erythropoietin Features
Table 4. Monoclonal antibodies Features
Table 5. Insulin Features
Table 6. Interferon Features
Table 7. Granulocyte-Colony Stimulating Factor Features
Table 8. Peptide Features
Table 9. Others Features
Table 11. Global Biosimilars/Follow-on-Biologics Market Share by Application: 2020 VS 2026
Table 12. Blood disorders Case Studies
Table 13. Oncology diseases Case Studies
Table 14. Chronic and autoimmune diseases Case Studies
Table 15. Growth hormone deficiencies Case Studies
Table 16. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biosimilars/Follow-on-Biologics Report Years Considered
Table 29. Global Biosimilars/Follow-on-Biologics Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biosimilars/Follow-on-Biologics Market Share by Regions: 2021 VS 2026
Table 31. North America Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 42. East Asia Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 43. Europe Biosimilars/Follow-on-Biologics Consumption by Region (2015-2020)
Table 44. South Asia Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 46. Middle East Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 47. Africa Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 48. Oceania Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 49. South America Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 50. Rest of the World Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 51. Novartis Biosimilars/Follow-on-Biologics Product Specification
Table 52. Merck Group Biosimilars/Follow-on-Biologics Product Specification
Table 53. LG Life Sciences Biosimilars/Follow-on-Biologics Product Specification
Table 54. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Specification
Table 55. Hospira Biosimilars/Follow-on-Biologics Product Specification
Table 56. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Specification
Table 57. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Specification
Table 58. Biocon Biosimilars/Follow-on-Biologics Product Specification
Table 59. Celltrion Biosimilars/Follow-on-Biologics Product Specification
Table 60. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Specification
Table 101. Global Biosimilars/Follow-on-Biologics Production Forecast by Region (2021-2026)
Table 102. Global Biosimilars/Follow-on-Biologics Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biosimilars/Follow-on-Biologics Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biosimilars/Follow-on-Biologics Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biosimilars/Follow-on-Biologics Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biosimilars/Follow-on-Biologics Sales Price Forecast by Type (2021-2026)
Table 107. Global Biosimilars/Follow-on-Biologics Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biosimilars/Follow-on-Biologics Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 111. Europe Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 115. Africa Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 117. South America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 119. Biosimilars/Follow-on-Biologics Distributors List
Table 120. Biosimilars/Follow-on-Biologics Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 2. North America Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 3. United States Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 8. China Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 12. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Region in 2020
Figure 13. Germany Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 15. France Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 23. South Asia Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 24. India Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 28. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 37. Middle East Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 38. Turkey Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 48. Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 55. Oceania Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 56. Australia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 58. South America Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 59. South America Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 60. Brazil Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 69. Rest of the World Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 71. Global Biosimilars/Follow-on-Biologics Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biosimilars/Follow-on-Biologics Price and Trend Forecast (2015-2026)
Figure 74. North America Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 95. East Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 96. Europe Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 97. South Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 99. Middle East Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 100. Africa Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 101. Oceania Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 102. South America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 103. Rest of the world Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Biosimilars/Follow-on-Biologics Market Share by Type: 2020 VS 2026
Table 2. Human growth hormone Features
Table 3. Erythropoietin Features
Table 4. Monoclonal antibodies Features
Table 5. Insulin Features
Table 6. Interferon Features
Table 7. Granulocyte-Colony Stimulating Factor Features
Table 8. Peptide Features
Table 9. Others Features
Table 11. Global Biosimilars/Follow-on-Biologics Market Share by Application: 2020 VS 2026
Table 12. Blood disorders Case Studies
Table 13. Oncology diseases Case Studies
Table 14. Chronic and autoimmune diseases Case Studies
Table 15. Growth hormone deficiencies Case Studies
Table 16. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biosimilars/Follow-on-Biologics Report Years Considered
Table 29. Global Biosimilars/Follow-on-Biologics Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biosimilars/Follow-on-Biologics Market Share by Regions: 2021 VS 2026
Table 31. North America Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biosimilars/Follow-on-Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 42. East Asia Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 43. Europe Biosimilars/Follow-on-Biologics Consumption by Region (2015-2020)
Table 44. South Asia Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 46. Middle East Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 47. Africa Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 48. Oceania Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 49. South America Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 50. Rest of the World Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
Table 51. Novartis Biosimilars/Follow-on-Biologics Product Specification
Table 52. Merck Group Biosimilars/Follow-on-Biologics Product Specification
Table 53. LG Life Sciences Biosimilars/Follow-on-Biologics Product Specification
Table 54. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Product Specification
Table 55. Hospira Biosimilars/Follow-on-Biologics Product Specification
Table 56. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Product Specification
Table 57. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Product Specification
Table 58. Biocon Biosimilars/Follow-on-Biologics Product Specification
Table 59. Celltrion Biosimilars/Follow-on-Biologics Product Specification
Table 60. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Product Specification
Table 101. Global Biosimilars/Follow-on-Biologics Production Forecast by Region (2021-2026)
Table 102. Global Biosimilars/Follow-on-Biologics Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biosimilars/Follow-on-Biologics Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biosimilars/Follow-on-Biologics Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biosimilars/Follow-on-Biologics Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biosimilars/Follow-on-Biologics Sales Price Forecast by Type (2021-2026)
Table 107. Global Biosimilars/Follow-on-Biologics Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biosimilars/Follow-on-Biologics Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 111. Europe Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 115. Africa Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 117. South America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026 by Country
Table 119. Biosimilars/Follow-on-Biologics Distributors List
Table 120. Biosimilars/Follow-on-Biologics Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 2. North America Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 3. United States Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 8. China Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 12. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Region in 2020
Figure 13. Germany Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 15. France Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 23. South Asia Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 24. India Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 28. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 37. Middle East Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 38. Turkey Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 48. Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 55. Oceania Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 56. Australia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 58. South America Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 59. South America Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 60. Brazil Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biosimilars/Follow-on-Biologics Consumption and Growth Rate
Figure 69. Rest of the World Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biosimilars/Follow-on-Biologics Consumption and Growth Rate (2015-2020)
Figure 71. Global Biosimilars/Follow-on-Biologics Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biosimilars/Follow-on-Biologics Price and Trend Forecast (2015-2026)
Figure 74. North America Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biosimilars/Follow-on-Biologics Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biosimilars/Follow-on-Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 95. East Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 96. Europe Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 97. South Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 99. Middle East Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 100. Africa Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 101. Oceania Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 102. South America Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 103. Rest of the world Biosimilars/Follow-on-Biologics Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
